Related Experiment Video
Updated: May 13, 2026

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
Published on: January 27, 2019
Chagas' cardiomyopathy: the economic burden of an expensive and neglected disease
Abrão Abuhab1, Evelinda Trindade, Gabriel Barros Aulicino
1Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil.
Insights
Chagas cardiomyopathy (CC) leads to higher hospitalization costs and mortality during acute decompensated heart failure (ADHF) admissions compared to other heart failure causes. This highlights the significant economic and health burden of CC.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Chagas cardiomyopathy (CC) is an emerging cause of heart failure (HF), with significant socioeconomic impact.
- CC's economic burden, especially during acute decompensated heart failure (ADHF) admissions, is understudied compared to other HF etiologies.
Purpose of the Study:
- To assess the cost burden of CC during ADHF admissions.
- To compare these costs with other HF etiologies.
Main Methods:
- A five-year follow-up of 577 consecutive adult patients admitted for ADHF in Sao Paulo, Brazil.
- Patients were divided into CC (58) and non-chagasic (NC) (519) groups.
- Analysis of mortality, signs of inadequate perfusion, and hospitalization costs per day.
Main Results:
- Mortality was significantly higher in the CC group (32.8%) versus the NC group (21.8%).
- CC patients exhibited a higher prevalence of inadequate perfusion signs at admission.
- Median daily hospitalization costs were higher for CC (US$467) compared to NC (US$308).
Conclusions:
- ADHF admissions due to CC are more expensive and associated with higher mortality.
- The severity of Chagas cardiomyopathy likely explains the increased costs and mortality.
Background:
Chagas' cardiomyopathy (CC) is a rising etiology for heart failure (HF) that previously was restricted to some countries of Latin America. The chronic CC cases cause now a profound socio-economic impact. However this issue has not been well studied if compared to other causes of HF. The objective of this study was to assess the cost burden of CC during acute decompensated HF admissions (ADHF), and compare this cost to the other etiologies of HF.
Methods And Results:
By the end of 2006 we started a five year follow-up of 577 consecutive adult patients admitted at a high complexity cardiology university hospital in the city of Sao Paulo, Brazil. This study shows the data of the first admission of each patient of this follow-up. Patients were divided in two groups: CC (58 patients) and non-chagasic (NC) (519 patients). Mortality was different among groups, 19/58 (32.8%) in CC vs 113/519 (21.8%) in NC (p=0.046). The prevalence of signs of inadequate perfusion was higher in the CC group at admission, but in a multivariated analysis chagasic etiology and presence of diabetes were independent predictors of higher costs per day of hospitalization adjusted by mortality. Median costs per day were US$ 308 (277-542) vs US$ 467 (323-815) for NC and CC respectively (p<0.001).
Conclusion:
Treating ADHF patients with CC etiology was more expensive and mortality was higher in this population at the first admission of this follow-up. This could be explained by the severity of Chagas' cardiomyopathy disease.
More Related Videos
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy VI: Nursing Management

